• HK Exclusive •

Require to set up a Hong Kong company

HKUST

US8389544

Title of Patent:

Isoquinolone compounds as subtype-selective agonists for melatonin receptors MT1 and MT2

• Isoquinolone compounds that are capable of modulating melatonin receptors and to pharmaceutical compositions containing such compounds for treating disorders or pathological conditions associated with melatonin receptors in mammalian subjects

• Method to treat, prevent or ameliorate a pathological condition in mammal

• Promising therapeutic agents used to treat insomnia and circadian-related disorders such as jet lag

Potential Areas of Applications:

• Medicine

• Healthcare

• Cure Sleep Disorders

• Pharmaceutical

Proposed Schemes:

Licensing

* Schemes are subject to the business model and are open for discussion.